Clinical Trial Update: Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a placebo-controlled Phase 1/2 study investigating dopaminergic mechanisms as drivers of mobility resilience in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinsonian Signs in Older Persons | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-06-17